Clinical Trials on Post-COVID ME/CFS in Switzerland

Total 10 results

University of Zurich

Recruiting

Pycnogenol® in Post-COVID-19 Condition (PYCNOVID)

Long COVID | Post COVID-19 Condition

Switzerland
University Hospital, Basel, Switzerland
State Secretariat for Education Research and Innovation, Switzerland; European...

Recruiting

Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy (BALCoS/DiLCoS)

Post COVID-19 Condition (PCC)

Switzerland
Simon Annaheim
Kliniken Valens, Klinik Gais

Recruiting

Disease-related Fatigue Monitoring Based on Body Signals Measured on the Skin (Fatignals)

Post-COVID-19 Related Fatigue

Switzerland
Arno Schmidt-Trucksäss

Recruiting

Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms (COR-PHYS)

Controls | Patients Post-COVID-19

Switzerland
Istituto Auxologico Italiano
Politecnico di Milano

Completed

Telerehabilitation in the Post-COVID-19 Patient (TRIALS)

Post-COVID-19 Syndrome

Switzerland, Italy
Berlin Cures GmbH

Active, not recruiting

To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID (BLOC)

Long Covid

Germany, Austria, Finland, Spain, Switzerland
Prof. Dominique de Quervain, MD
University Hospital, Basel, Switzerland; Clinical Trial Unit, University Hospital...

Active, not recruiting

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment (FamC)

Working Memory | Post-covid-19

Switzerland
GeNeuro SA

Completed

Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Post-COVID-19 Syndrome

Switzerland, Italy, Spain
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Terminated

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study (MEADOWSPRING)

COVID-19 | Long COVID

Denmark, Switzerland, Turkey, Belgium, Mexico, Brazil, Argentina, Germany, Romania, Ukraine
University Hospital, Basel, Switzerland
Swiss Multiple Sclerosis Registry

Recruiting

A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. (MS COVID-19)

Multiple Sclerosis | COVID-19 (Severe Coronavirus Disease 2019)

Switzerland

Clinical Trials on Post-COVID ME/CFS in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations